Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients

Clinical trial NCT00767546 · UNKNOWN

Trial details

NCT number: NCT00767546
Sponsor: Rabin Medical Center
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Parkinson Disease Parkinsonism Seborrheic Dermatitis

Start date: 2009-05-01
Primary completion: 2010-08-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.